Der er også risiko for kardiotoksicitet hos patienter, som tidligere har fået anthracykliner, selvom risikoen er mindre end ved samtidig anvendelse af Herceptin og anthracykliner.
Patients who have previously received anthracyclines are also at risk of cardiotoxicity with Herceptin treatment, although the risk is lower than with concurrent use of Herceptin and anthracyclines.